Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treosulfan Conditioning Before HSCT in Nijmegen Breakage Syndrome
NCT07316595Phase 2Not yet recruiting
- Sponsor
- Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology
- Start
- Dec 2025
- Primary completion
- Dec 2028
- Modality
- DNA Intercalators/Alkylators
01
Overview
A Phase 2 trial of treosulfan in Nijmegen breakage syndrome (NBS), sponsored by Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
treosulfan
03
Conditions
Nijmegen breakage syndrome (NBS)
Beyond the preview
Go deeper on NCT07316595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07316595.